MediciNova Inc (MNOV.OQ)
MNOV.OQ on NASDAQ Stock Exchange Global Market
2.63USD
10:58am EDT
2.63USD
10:58am EDT
Price Change (% chg)
$0.03 (+1.15%)
$0.03 (+1.15%)
Prev Close
$2.60
$2.60
Open
$2.63
$2.63
Day's High
$2.63
$2.63
Day's Low
$2.63
$2.63
Volume
100
100
Avg. Vol
21,307
21,307
52-wk High
$4.65
$4.65
52-wk Low
$1.51
$1.51
About
MediciNova, Inc. is a development-stage biopharmaceutical company focused on acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs with a focus on the United States market. Through strategic alliances, primarily with Japanese pharmaceutical companies, it holds rights... (more)
No analyst recommendations are available for MNOV.OQ.
Overall
| Beta: | 1.46 |
| Market Cap (Mil.): | ¥5,522.28 |
| Shares Outstanding (Mil.): | 21.21 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| MNOV.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 44.65 | 37.87 |
| EPS (TTM): | -55.45 | -- | -- |
| ROI: | -- | -2.30 | 18.70 |
| ROE: | -- | -2.12 | 19.53 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: S&P Capital IQ Quantitative Report
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

